SOMERSET, N.J., Feb. 19, 2013 /PRNewswire/ — Terumo Medical Corporation (Terumo), today announced that it has filed a patent infringement lawsuit against Vascular Solutions Inc. and Lepu Medical Technology (Beijing) Co., Ltd in the U.S. District Court of New Jersey.
The complaint alleges that R Band™ Radial Hemostasis Device distributed by Vascular Solutions and manufactured by Lepu Medical Technology infringes on a patent and trademark, which Terumo Medical Corporation holds the U.S. rights to for its proprietary TR Band™ Radial Compression Device. Terumo seeks an injunction against further sales of the violative product.
“Terumo has made an enormous investment in developing intellectual property and absorbing costs associated with device design and commercialization of our transradial technology. The Terumo TR Band™ device is a critical part of our transradial solutions portfolio. We will vigorously take all steps necessary to ensure that our assets and intellectual property are protected,” said Gael Tisack , Vice President of Intellectual Property, Terumo Americas Holding.
Terumo Interventional Systems
Terumo Interventional Systems (TIS) is a strategic business unit of Terumo Medical Corporation. As a market leader in entry site management and lesion access, TIS is committed to pursuing unique technologies designed to enhance treatment of coronary and peripheral endovascular diseases as well as driving strategic initiatives focused on Critical Limb Ischemia, Complex Coronary Intervention and Transradial Access.
TIS directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures.
Terumo Medical Corporation
Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures, and markets a complete, solutions-based portfolio of high-quality medical devices used in a broad range of applications for numerous areas of the healthcare industry. TMC is comprised of two business divisions: Terumo Interventional Systems and Terumo Medical Products. The company places a premium on providing customers with world-class products, training and education programs that drive clear economic value, better clinical outcomes and improved Quality of Life for patients.
Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with
$5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve.
Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan’s leading stock index.